Hyuk Soon Kim

Prof. Hyuk Soon Kim

Biomedical Sciences, Dong-A University, Busan, Republic of Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
JMJeong-Yeon Mun
Jeong-Yeon Mun
SLSun-Hee Leem
Sun-Hee Leem
JLJun Ho Lee
Jun Ho Lee
HKHyuk Soon Kim
Hyuk Soon Kim
The tumor microenvironment (TME) plays a critical role in tumorigenesis and is comprised of different components, including tumor cells, stromal cells, and immune cells. Among them, the relationship between each mediator involved in the construction of the TME can be understood by focusing on the secreting or expressing factors from each cells. Therefore, understanding the various interactions between each cellular component of the TME is necessary for precise therapeutic approaches. In carcinoma, stromal cells are well known to influence extracellular matrix (ECM) formation and tumor progression through multiple mediators. Immune cells respond to tumor cells by causing cytotoxicity or inflammatory responses. However, they are involved in tumor escape through immunoregulatory mechanisms. In general, anti-cancer therapy has mainly been focused on cancer cells themselves or the interactions between cancer cells and specific cell components. However, cancer cells directly or indirectly influence other TME partners, and members such as stromal cells and immune cells also participate in TME organization through their mutual communication. In this review, we summarized the relationship between stromal cells and immune cells in the TME and discussed the positive and negative relationships from the point of view of tumor development for use in research applications and therapeutic strategies.

15 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
HKHyuk Soon Kim
Hyuk Soon Kim
SNSeung Taek Nam
Seung Taek Nam
SMSe Hwan Mun
Se Hwan Mun
SLSun-Kyeong Lee
Sun-Kyeong Lee
HKHyun Woo Kim
Hyun Woo Kim
WCWahn Soo Choi
Wahn Soo Choi
Receptor activator of NF-kB ligand (RANKL) generates intracellular reactive oxygen species (ROS), which increase RANKL-mediated signaling in osteoclast (OC) precursor bone marrow macrophages (BMMs). Here we show that a ROS scavenging protein DJ-1 negatively regulates RANKL-driven OC differentiation, also called osteoclastogenesis. DJ-1 ablation in mice leads to a decreased bone volume and an increase in OC numbers. In vitro, the activation of RANK-dependent signals is enhanced in DJ-1-deficient BMMs as compared to wild-type BMMs. DJ-1 suppresses the activation of both RANK-TRAF6 and RANK-FcRγ/Syk signaling pathways because of activation of Src homology region 2 domain-containing phosphatase-1, which is inhibited by ROS. Ablation of DJ-1 in mouse models of arthritis and RANKL-induced bone disease leads to an increase in the number of OCs, and exacerbation of bone damage. Overall, our results suggest that DJ-1 plays a role in bone homeostasis in normal physiology and in bone-associated pathology by negatively regulating osteoclastogenesis.

8 June 2010 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
SMSe Hwan Mun
Se Hwan Mun
NKNa Young Ko
Na Young Ko
HKHyuk Soon Kim
Hyuk Soon Kim
JKJie Wan Kim
Jie Wan Kim
DKDo Kyun Kim
Do Kyun Kim
WCWahn Soo Choi
Wahn Soo Choi

1 May 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
DLDajeong Lee
Dajeong Lee
HKHyuk Soon Kim
Hyuk Soon Kim
ESEunju Shin
Eunju Shin
SDSeon-Gil Do
Seon-Gil Do
CLChong-Kil Lee
Chong-Kil Lee
WCWahn Soo Choi
Wahn Soo Choi

1 January 2010 in Cellular Immunology
Verified
Journal Article
Closed access
JNJoonyong Noh
Joonyong Noh
JLJae Ho Lee
Jae Ho Lee
GNGeunwoong Noh
Geunwoong Noh
SBSo Young Bang
So Young Bang
HKHyuk Soon Kim
Hyuk Soon Kim
SLSang Sun Lee
Sang Sun Lee

26 February 2009 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
SMSe Hwan Mun
Se Hwan Mun
JKJie Wan Kim
Jie Wan Kim
SNSeong Su Nah
Seong Su Nah
NKNa Young Ko
Na Young Ko
JLJunho H Lee
Junho H Lee
WCWahn Soo Choi
Wahn Soo Choi
Objective: Interleukin‐32 (IL‐32) is a recently discovered cytokine that appears to play a critical role in human rheumatoid arthritis (RA). It is highly expressed in synovium and fibroblast‐like synoviocytes (FLS) from RA patients, but not in patients with osteoarthritis (OA). This study was undertaken to assess IL‐32 levels in RA synovial fluid (SF) and to investigate the secretion and regulation of IL‐32 in RA FLS.Methods: FLS and SF were obtained from the joints of RA patients. The secretion and expression of IL‐32 and activation of signaling molecules were examined by enzyme‐linked immunosorbent assay, immunoblotting, immunoprecipitation, reverse transcriptase–polymerase chain reaction, and small interfering RNA (siRNA) transfection.Results: IL‐32 levels were high in RA SF compared with OA SF. Furthermore, RA FLS expressed and secreted IL‐32 when stimulated with tumor necrosis factor α (TNFα). TNFα‐induced expression of IL‐32 was significantly suppressed, in a dose‐dependent manner, by inhibitors of Syk, protein kinase Cδ (PKCδ), and JNK and by knockdown of these kinases and c‐Jun with siRNA. We also observed that PKCδ mediated the activation of JNK and c‐Jun, and experiments using specific inhibitors and siRNA demonstrated that Syk was the upstream kinase for the activation of PKCδ.Conclusion: The present findings suggest that IL‐32 may be a newly identified prognostic biomarker in RA, thereby adding valuable knowledge to the understanding of this disease. The results also demonstrate that the production of IL‐32 in RA FLS is regulated by Syk/PKCδ‐mediated signaling events.